Your browser doesn't support javascript.
loading
Parallel neurodegenerative phenotypes in sporadic Parkinson's disease fibroblasts and midbrain dopamine neurons.
Corenblum, M J; McRobbie-Johnson, A; Carruth, E; Bernard, K; Luo, M; Mandarino, L J; Peterson, S; Sans-Fuentes, M A; Billheimer, D; Maley, T; Eggers, E D; Madhavan, L.
Affiliation
  • Corenblum MJ; Department of Neurology, University of Arizona, Tucson, AZ, United States.
  • McRobbie-Johnson A; Physiological Sciences Graduate Program, University of Arizona, Tucson, AZ, United States.
  • Carruth E; Physiology Undergraduate Program, University of Arizona, Tucson, AZ, United States.
  • Bernard K; Physiological Sciences Graduate Program, University of Arizona, Tucson, AZ, United States.
  • Luo M; Department of Medicine, University of Arizona, Tucson, AZ, United States.
  • Mandarino LJ; Department of Medicine, University of Arizona, Tucson, AZ, United States.
  • Peterson S; Statistical Consulting Lab, BIO5 Institute, University of Arizona, Tucson, AZ, United States.
  • Sans-Fuentes MA; Statistical Consulting Lab, BIO5 Institute, University of Arizona, Tucson, AZ, United States.
  • Billheimer D; Statistical Consulting Lab, BIO5 Institute, University of Arizona, Tucson, AZ, United States.
  • Maley T; Physiological Sciences Graduate Program, University of Arizona, Tucson, AZ, United States.
  • Eggers ED; Departments of Physiology and Biomedical Engineering, University of Arizona, Tucson, AZ, United States.
  • Madhavan L; Department of Neurology, University of Arizona, Tucson, AZ, United States; Evelyn F McKnight Brain Institute and BIO5 Institute, University of Arizona, Tucson, AZ, United States. Electronic address: lmadhavan@arizona.edu.
Prog Neurobiol ; 229: 102501, 2023 10.
Article in En | MEDLINE | ID: mdl-37451330
ABSTRACT
Understanding the mechanisms causing Parkinson's disease (PD) is vital to the development of much needed early diagnostics and therapeutics for this debilitating condition. Here, we report cellular and molecular alterations in skin fibroblasts of late-onset sporadic PD subjects, that were recapitulated in matched induced pluripotent stem cell (iPSC)-derived midbrain dopamine (DA) neurons, reprogrammed from the same fibroblasts. Specific changes in growth, morphology, reactive oxygen species levels, mitochondrial function, and autophagy, were seen in both the PD fibroblasts and DA neurons, as compared to their respective controls. Additionally, significant alterations in alpha synuclein expression and electrical activity were also noted in the PD DA neurons. Interestingly, although the fibroblast and neuronal phenotypes were similar to each other, they differed in their nature and scale. Furthermore, statistical analysis revealed potential novel associations between various clinical measures of the PD subjects and the different fibroblast and neuronal data. In essence, these findings encapsulate spontaneous, in-tandem, disease-related phenotypes in both sporadic PD fibroblasts and iPSC-based DA neurons, from the same patient, and generates an innovative model to investigate PD mechanisms with a view towards rational disease stratification and precision treatments.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Induced Pluripotent Stem Cells Type of study: Prognostic_studies Limits: Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Induced Pluripotent Stem Cells Type of study: Prognostic_studies Limits: Humans Language: En Year: 2023 Type: Article